From single-compound target screening to full-phase preclinical pharmacodynamics and clinical translation, access our core manufacturing and testing services.
How modern contract manufacturing has evolved into an analytical, data-intensive discipline powered by molecular phytochemistry, chromatographic validation, and regulatory compliance.
Global nutraceutical, pharmaceutical, and cosmeceutical developers face an unprecedented squeeze: international regulatory authorities (US FDA, EMA, NMPA) no longer accept crude herbal powders with ambiguous markers. Sourcing executives now mandate defined, reproducible active chemical profiles, documented botanical origins, zero pesticide cross-contamination, and strict heavy metal thresholds.
Raw botanical materials exhibit significant chemical variance caused by soil chemistry, seasonal rainfall, altitude, and post-harvest drying protocols. Yineng Pharma (MedGence) bridges this vulnerability by operating as a hybrid CRO-CDMO that de-risks upstream raw procurement through continuous high-throughput molecular screening and geo-origin profiling.
A primary barrier preventing international brands from capitalizing on Asian contract manufacturing is intellectual property preservation. MedGence enforces closed-loop contractual isolation: proprietary client target structures, fractionation methods, and finished recipes are completely protected under legal non-disclosure and segregated pilot line manufacturing.
MedGence (Yineng Pharma), headquartered in Changsha, Hunan, provides comprehensive contract research and industrial CDMO production. Having partnered with over 100 regulated pharmaceutical enterprises and clinical university hospitals, we have achieved modern clinical validations for 83 classic Traditional Chinese Medicine (TCM) formulas, developed 22 approved innovative natural products, and registered 56 specialized hospital preparations.
Discover how modern computational phytochemistry, continuous-flow extraction, and intelligent analytics provide western buyers with unmatched consistency, scale, and cost parity.
Traditional trial-and-error extraction takes months. Our intelligent chemometric modeling platforms correlate target biological receptor bindings with plant fractions in days. By cross-referencing multi-omics mass spectrometry with historical botanical libraries, we predict optimal solvent polarities, resin selectivity, and extraction thermodynamics before running pilot runs.
Our state-of-the-art facilities implement online Process Analytical Technology (PAT). Critical manufacturing parameters—such as rotary evaporation temperatures, countercurrent extraction dwell times, column chromatography flow dynamics, and spray drying thermal gradients—are regulated by computerized SCADA interfaces, eliminating human handling errors.
China's geographic diversity provides unmatched agro-climatic niches for wild and cultivated medicinal botany. MedGence pairs this resource with Good Agricultural Practices (GAP) field monitoring. Each commercial batch is tied to geospatial coordinate data, soil heavy-metal mapping, climate logs, and precise harvest cycles to guarantee absolute purity.
| R&D / CDMO Phase | Technical Objective | Analytical Equipment Deployed | Primary Industrial Deliverable |
|---|---|---|---|
| Phase 01: Sourcing & Screen | Identify optimal bioactive fractions across seasonal & geographical cohorts. | UPLC-QTOF-MS, GC-MS, HPTLC Fingerprint | Active Origin & Harvesting Spec |
| Phase 02: Analytical Standard | Validate quantitative and qualitative test methods for QC release. | HPLC-DAD, Triple Quadrupole LC-MS/MS | Validated Assay SOP & COA Standard |
| Phase 03: Pilot Process Design | Establish thermodynamic parameters for extraction, crystallization & purification. | Membrane Separation, Supercritical CO2, Pilot Spray Dryers | Key Process Parameters (KPP) Dossier |
| Phase 04: Preclinical & Safety | Perform acute toxicity (LD50), Ames genotoxicity & in vitro cell assays. | Flow Cytometry, Automated Microplate Cell Assays | GLP Toxicology & Efficacy Package |
| Phase 05: Clinical Translation | Execute human dietary cohort evaluations or Phase I–IV clinical protocols. | GCP Clinical Data Management Systems (CDMS) | Statistically Verified Human Study Report |
| Phase 06: CDMO Manufacture | Commercial cGMP production of active liquids, powders, capsules or tablets. | Automated Capsule Fillers, Cleanroom Liquid Lines | Commercial Batch Supply + Retain Records |
How Fortune 500 nutraceuticals, multinational pharmaceutical developers, and emerging biotech brands mitigate quality vulnerabilities through our comprehensive qualification infrastructure.
Whether your enterprise is filing a New Dietary Ingredient (NDI) notification, asserting GRAS (Generally Recognized As Safe) self-determination, or pursuing a botanical Investigational New Drug (IND) under FDA 21 CFR Part 312, MedGence supplies all necessary chemical consistency documentation, CMC packages, and GLP toxicity trials.
European buyers require strict compliance with EFSA Novel Food regulations, European Pharmacopoeia (Ph. Eur.) monographs, and EMA Traditional Herbal Medicinal Products Directives (THMPD). Our analytical validation directly addresses polycyclic aromatic hydrocarbons (PAHs), ethylene oxide (ETO), aflatoxins, pyrrolizidine alkaloids, and heavy metal limits down to parts-per-billion (ppb).
We standardize every stage using International Council for Harmonisation (ICH) guidelines. Our Q2(R1) validation packages for analytical procedures confirm linearity, accuracy, precision (repeatability and intermediate precision), specificity, detection limits, and quantitation limits, delivering complete audit readiness.
Real-world commercial scenarios showing how our end-to-end contract R&D accelerates project launches for functional foods, therapeutic drugs, and clean cosmetics.
Client Challenge: A North American sports nutrition brand required a natural active to optimize metabolic recovery and blood-glucose modulation without using synthetic stimulants.
Our Execution: MedGence screened 14 botanical candidates, pinpointing a high-yield polyphenol/saponin fraction from an indigenous high-altitude botanical. We performed origin-potency studies, developed a validated HPLC assay, verified bioavailability via in vitro intestinal transport models, and manufactured 200,000 finished vegetarian capsule units in our cGMP cleanrooms.
Client Challenge: An Asian biopharma group sought to modernize a historic 8-herb prescription formula for respiratory inflammatory indications to secure regional hospital registration.
Our Execution: We developed chromatographic fingerprinting across 30 production batches, established precise markers for each botanical constituent, mapped GLP acute and 90-day chronic toxicity profiles in murine models, and organized Phase I/II clinical trials involving 240 human subjects. Results supported successful regulatory hospital preparation approval.
Client Challenge: A European luxury skincare enterprise needed a clean-label, plant-derived active targeting cellular senescence, tyrosinase inhibition, and barrier repair.
Our Execution: Using solvent-free supercritical CO2 and green enzymatic extraction, we produced a pale, low-odor, standardized flavonoid concentrate. We proved cellular safety and skin-barrier upregulation through 3D reconstructed human epidermis assays, providing the regulatory documentation required for global cosmetic ingredient registration.
Our contract research leadership is built on active development programs alongside top-tier pharmaceutical groups, state institutions, and university teaching hospitals.
In-depth guidance covering analytical methodologies, regulatory filings, IP encasement, pilot-to-scale parameters, and commercial OEM batch delivery.
Select individual research modules or configure a turnkey program spanning target identification, bioassay validation, pilot scale-up, and commercial production.
Whether you require targeted active molecule screening, chromatographic assay method establishment, toxicology validation, or end-to-end CDMO commercial manufacturing, our technical leadership will prepare a comprehensive project brief with timelines and deliverables.
